WELLS FARGO & COMPANY/MN - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,804,157
-41.5%
135,926
-16.4%
0.00%0.0%
Q2 2023$4,796,974
+66.5%
162,554
+30.0%
0.00%0.0%
Q1 2023$2,881,612
+60.2%
125,070
+93.3%
0.00%0.0%
Q4 2022$1,799,001
-9.6%
64,689
-0.3%
0.00%0.0%
Q3 2022$1,991,000
-2.3%
64,887
-6.2%
0.00%0.0%
Q2 2022$2,037,000
-42.6%
69,206
-37.2%
0.00%0.0%
Q1 2022$3,547,000
-44.6%
110,268
-23.2%
0.00%
-50.0%
Q4 2021$6,402,000
-23.0%
143,536
-12.9%
0.00%0.0%
Q3 2021$8,311,000
-28.3%
164,745
+11.5%
0.00%
-33.3%
Q2 2021$11,592,000
+74.8%
147,773
+27.3%
0.00%
+200.0%
Q1 2021$6,631,000
-36.0%
116,124
-6.1%
0.00%
-50.0%
Q4 2020$10,361,000
+237.2%
123,694
+44.3%
0.00%
+100.0%
Q3 2020$3,073,000
+58.8%
85,749
+7.2%
0.00%0.0%
Q2 2020$1,935,000
-30.7%
79,999
-49.8%
0.00%0.0%
Q1 2020$2,791,000
+10.3%
159,339
+9.7%
0.00%0.0%
Q4 2019$2,531,000
+13.2%
145,257
-0.4%
0.00%0.0%
Q3 2019$2,235,000
-22.8%
145,888
+4.6%
0.00%0.0%
Q2 2019$2,895,000
+71.6%
139,424
+91.9%
0.00%0.0%
Q1 2019$1,687,000
+9.5%
72,651
-2.5%
0.00%0.0%
Q4 2018$1,540,000
+2.1%
74,510
+7.5%
0.00%
Q3 2018$1,508,000
+76.8%
69,330
+24.0%
0.00%
Q2 2018$853,000
-22.2%
55,920
+0.5%
0.00%
Q1 2018$1,096,000
+76.5%
55,647
+40.2%
0.00%
Q4 2017$621,00039,7000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders